Beyond Air (XAIR) Capital Expenditures Growth (1y) (2018 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -17.56% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 34.96% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -6.72% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -5.35% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 15.89% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -47.73% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -11.95% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -43.42% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 27.22% |
| 10 | Beyond Air | 3.27 Mn | -6.59 Mn | 300,000.00 | -93.67% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -93.67% |
| Sep 30, 2025 | -79.06% |
| Jun 30, 2025 | -92.59% |
| Mar 31, 2025 | -22.42% |
| Dec 31, 2024 | -59.84% |
| Sep 30, 2024 | -30.14% |
| Jun 30, 2024 | 236.23% |
| Mar 31, 2024 | -4.50% |
| Dec 31, 2023 | 110.88% |
| Sep 30, 2023 | 74.66% |
| Jun 30, 2023 | 208.14% |
| Mar 31, 2023 | 491.23% |
| Dec 31, 2022 | 51.31% |
| Sep 30, 2022 | 62.67% |
| Jun 30, 2022 | 855.56% |
| Mar 31, 2022 | 1,610.00% |
| Dec 31, 2021 | 201.44% |
| Sep 30, 2021 | 21.44% |
| Jun 30, 2021 | -88.91% |
| Mar 31, 2021 | 30.01% |
| Dec 31, 2020 | 1,222.30% |
| Sep 30, 2020 | 3,233.38% |
| Jun 30, 2020 | 7,725.42% |
| Mar 31, 2020 | 264.87% |
| Dec 31, 2019 | -33.35% |
| Mar 31, 2019 | 321.60% |
| Dec 31, 2018 | -92.81% |
| Mar 31, 2018 | -96.03% |